MabSwitch

Funding and NIH signals

• NIH award NIH awarded $400K (SBIR Phase I 1R43CA310118-01, new, notice Sep 17, 2026); 2 NIH awards totaling $800K in the last 12 months. NIH RePORTER 1R43CA310118-01 (Sep 17, 2026)
  Evidence (2 events)

  • Sep 17, 2026 · NIH RePORTER 1R43CA310118-01
    Organization: MABSWITCH, INC.; City/State: VAN NUYS, CA; Project number: 1R43CA310118-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 399998; Administering IC: National Cancer Institute; Project title: Remote-Controlled PC-CAR T-Cell Therapy for Hard-to-Treat Solid Tumors; Organization type: Domestic For-Profits
  • Sep 10, 2026 · NIH RePORTER 1R43CA314526-01
    Organization: MABSWITCH, INC.; City/State: VAN NUYS, CA; Project number: 1R43CA314526-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-10; FY total cost (award amount): 399992; Administering IC: National Cancer Institute; Project title: Affinity-tunable Antibody Drug Conjugate (ADC) against High-Grade Serous Ovarian Cancer; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals